IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis-Reference-Cited by-同舟云学术

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

Published:2018-08-23 Issue:16 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Gross Amy C.,Cam Hakan,Phelps Doris A.,Saraf Amanda J.,Bid Hemant K.,Cam Maren,London Cheryl A.,Winget Sarah A.,Arnold Michael A.,Brandolini Laura^ORCID,Mo Xiaokui,Hinckley John M.,Houghton Peter J.,Roberts Ryan D.

Funder

National Institutes of Health

St Baldrick’s Foundation

QuadW Foundation-AACR Fellowship for Clinical/Translational Sarcoma Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/99791/files/pdf

Reference47 articles.

1. Osteosarcoma incidence and survival rates from 1973 to 2004

2. Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

3. Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

4. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

5. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma;Journal for ImmunoTherapy of Cancer;2024-07

2. Metastasis-initiating osteosarcoma subpopulations establish paracrine interactions with both lung and tumor cells to create a metastatic niche;2024-06-10

3. Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity;Pharmaceuticals;2024-06-05

4. NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis;Cancer Letters;2024-06

5. Advances in prognostic models for osteosarcoma risk;Heliyon;2024-04